Method for post coital contraception in overweight or obese female subjects using ulipristal acetate
AssigneeLaboratoire Hra-Pharma
InventorsDelphine Levy, Andre Ulmann, Henri Camille Mathe, Erin Gainer
Life of this patent
Estimating the term…
Abstract
The invention provides a method for providing post coital contraception in a female subject, comprising providing the subject with a therapeutically effective amount of ulipristal acetate, wherein the female subject is overweight or obese.
Claims9
A method for providing emergency contraception, comprising the step of administering to a woman about 30 mg of ulipristal acetate by oral route after an unprotected intercourse, wherein the woman is overweight having as body mass index (BMI) between about 25 and about 30.
A method for providing emergency contraception, comprising the step of administering to a woman about 30 mg of ulipristal acetate by oral route within about 120 hours after an unprotected intercourse, wherein the woman is overweight having a body mass index (BMI) between about 25 and about 30.
Dependencies are inferred from the claim text.